PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Review of scheduled, unscheduled, and foreign GMP inspections of pharmaceutical production facilities (June 2026)
This analytical review is based on official data obtained...
Experts continue to discuss possible changes to the regulations governing veterinary drugs in the EAEU
On June 23, a working meeting of experts was...
GMP Registry Update: 7 New Certificates and 2 Refusals in Late April 2026
The Ministry of Industry and Trade of the Russian...
Dmitry Kudlay: Russian Technologies Break Into the Global Stage But Stall in Public Procurement
Russian pharmaceutical science has reached a level where innovative...
